IS7926A - 4-útskipt bensímídasól og notkun þeirra sem magasýruseytishemla - Google Patents

4-útskipt bensímídasól og notkun þeirra sem magasýruseytishemla

Info

Publication number
IS7926A
IS7926A IS7926A IS7926A IS7926A IS 7926 A IS7926 A IS 7926A IS 7926 A IS7926 A IS 7926A IS 7926 A IS7926 A IS 7926A IS 7926 A IS7926 A IS 7926A
Authority
IS
Iceland
Prior art keywords
antacids
substituted benzimidazole
benzimidazole
substituted
Prior art date
Application number
IS7926A
Other languages
English (en)
Inventor
Buhr Wilm
Jan Zimmermann Peter
Vittoria Chiesa M.
Palmer Andreas
Brehm Christof
Grundler Gerhard
Senn-Bilfinger Jörg
Simon Wolfgang-Alexander
Postius Stefan
Kromer Wolfgang
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of IS7926A publication Critical patent/IS7926A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IS7926A 2002-12-13 2005-07-01 4-útskipt bensímídasól og notkun þeirra sem magasýruseytishemla IS7926A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027874 2002-12-13
EP03021348 2003-09-20
PCT/EP2003/014069 WO2004054984A1 (en) 2002-12-13 2003-12-11 4-substituted benzimidazoles and their use as inhibitors of gastric secretion

Publications (1)

Publication Number Publication Date
IS7926A true IS7926A (is) 2005-07-01

Family

ID=32598782

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7926A IS7926A (is) 2002-12-13 2005-07-01 4-útskipt bensímídasól og notkun þeirra sem magasýruseytishemla

Country Status (19)

Country Link
US (1) US20060194969A1 (is)
EP (1) EP1575924A1 (is)
JP (1) JP2006511600A (is)
KR (1) KR20050084170A (is)
AR (1) AR043063A1 (is)
AU (1) AU2003294831A1 (is)
BR (1) BR0317041A (is)
CA (1) CA2508838A1 (is)
CO (1) CO5580786A2 (is)
EA (1) EA008779B1 (is)
HR (1) HRP20050612A2 (is)
IS (1) IS7926A (is)
MX (1) MXPA05006052A (is)
NO (1) NO20053242D0 (is)
NZ (1) NZ540862A (is)
PL (1) PL375820A1 (is)
RS (1) RS20050435A (is)
TW (1) TW200504031A (is)
WO (1) WO2004054984A1 (is)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR043962A1 (es) 2003-04-04 2005-08-17 Altana Pharma Ag Compuestos derivados de bencimidazol, medicamentos que los contienen y su uso para preparar dichos medicamentos.
AR049168A1 (es) * 2004-05-18 2006-07-05 Altana Pharma Ag Derivados de benzimidazol
CA2589448A1 (en) * 2004-12-09 2006-06-15 Altana Pharma Ag Substituted imidazo[4,5-b]pyridines as inhibitors of gastric acid secretion
EP1910313A1 (en) * 2005-03-24 2008-04-16 Nycomed GmbH 6-thioamide substituted benzimidazoles
CA2608582A1 (en) 2005-06-14 2006-12-21 Pfizer Inc. Chromane substituted benzimidazole derivatives as acid pump antagonists
AR057061A1 (es) * 2005-06-16 2007-11-14 Altana Pharma Ag Espiro-bencimidazoles farmaceuticamente activos y su uso en la fabricacion de medicamentos
JP2009504798A (ja) * 2005-08-22 2009-02-05 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 同位体置換されたベンゾイミダゾール誘導体
WO2007031860A1 (en) * 2005-09-15 2007-03-22 Pfizer Japan Inc. Indane substituted benzimidazoles and their use as acid pump inhibitors
WO2007072142A2 (en) * 2005-12-19 2007-06-28 Pfizer Japan Inc. Benzimidazole-5-carboxamide derivatives
KR101088247B1 (ko) * 2005-12-19 2011-11-30 라퀄리아 파마 인코포레이티드 크로메인 치환된 벤즈이미다졸 및 이들의 산 펌프억제제로서의 용도
WO2008017466A1 (en) * 2006-08-08 2008-02-14 Nycomed Gmbh Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives
CA2657550C (en) 2006-09-21 2011-11-01 Raqualia Pharma Inc. Benzimidazole derivatives as selective acid pump inhibitors
WO2008071765A1 (en) * 2006-12-14 2008-06-19 Nycomed Gmbh Pharmaceutically active spiro-substituted benzimidazole derivatives
WO2008084067A2 (en) * 2007-01-12 2008-07-17 Nycomed Gmbh Pharmaceutically active dihydrobenzofurane-substituted benzimidazole derivatives
WO2008151927A2 (en) * 2007-06-15 2008-12-18 Nycomed Gmbh 6-n-substituted benz imidazole derivatives as acid pump antagonists
US8461177B2 (en) * 2007-08-27 2013-06-11 Siga Technologies, Inc. Antiviral drugs for treatment of arenavirus infection
WO2010081670A2 (en) * 2009-01-14 2010-07-22 Lonza Ltd Process for the preparation of benzimidazoles
CN105919998B (zh) 2009-07-09 2021-08-24 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂
WO2012081036A2 (en) * 2010-12-13 2012-06-21 Sequent Scientific Limited A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
RU2506259C1 (ru) * 2012-12-04 2014-02-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный университет им. П.Г. Демидова" Способ получения 4-{4-амино-2-хлоро-5-[(5-хлоро-2-метил-1н-бензимидазол-6-ил)амино]фенокси}бензойной кислоты
AU2014214561C1 (en) 2013-02-11 2019-01-17 Mitokinin, Inc. Compositions and methods for treating neurodegenerative diseases
SI3010503T1 (sl) 2013-06-21 2020-07-31 Zenith Epigenetics Ltd. Novi biciklični inhibitorji bromodomene
EP3010917B1 (en) 2013-06-21 2018-01-31 Zenith Epigenetics Ltd. Novel substituted bicyclic compounds as bromodomain inhibitors
KR101472686B1 (ko) 2013-07-09 2014-12-16 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 제조방법
JP6542212B2 (ja) 2013-07-31 2019-07-10 ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. ブロモドメイン阻害剤としての新規キナゾリノン
CA2966298A1 (en) 2014-12-01 2016-06-09 Zenith Epigenetics Ltd. Substituted pyridinones as bromodomain inhibitors
CA2966449A1 (en) 2014-12-11 2016-06-16 Zenith Epigenetics Ltd. Substituted heterocycles as bromodomain inhibitors
CA2966450A1 (en) 2014-12-17 2016-06-23 Olesya KHARENKO Inhibitors of bromodomains
KR101684053B1 (ko) * 2015-01-20 2016-12-08 씨제이헬스케어 주식회사 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법
KR20160144927A (ko) * 2015-06-08 2016-12-19 씨제이헬스케어 주식회사 야간 산 분비에 대한 벤즈이미다졸 유도체의 용도
CA3067695A1 (en) 2017-06-21 2018-12-27 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
CA3128809A1 (en) * 2019-02-04 2020-08-13 Simon Fraser University Methods and compounds for inhibition of inactivation of voltage-gated sodium channels
CN113527272B (zh) * 2021-08-06 2023-07-21 西安淳甄新材料有限公司 一种特戈拉赞的合成方法
KR20230099093A (ko) 2021-12-27 2023-07-04 에이치케이이노엔 주식회사 벤즈이미다졸 유도체의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SE9602286D0 (sv) * 1996-06-10 1996-06-10 Astra Ab New compounds

Also Published As

Publication number Publication date
NZ540862A (en) 2008-07-31
PL375820A1 (en) 2005-12-12
TW200504031A (en) 2005-02-01
KR20050084170A (ko) 2005-08-26
CO5580786A2 (es) 2005-11-30
MXPA05006052A (es) 2005-08-18
EP1575924A1 (en) 2005-09-21
RS20050435A (en) 2007-08-03
AR043063A1 (es) 2005-07-13
EA200500895A1 (ru) 2005-12-29
AU2003294831A1 (en) 2004-07-09
CA2508838A1 (en) 2004-07-01
US20060194969A1 (en) 2006-08-31
WO2004054984A1 (en) 2004-07-01
HRP20050612A2 (en) 2006-08-31
NO20053242L (no) 2005-07-01
EA008779B1 (ru) 2007-08-31
BR0317041A (pt) 2005-10-25
JP2006511600A (ja) 2006-04-06
NO20053242D0 (no) 2005-07-01

Similar Documents

Publication Publication Date Title
IS7926A (is) 4-útskipt bensímídasól og notkun þeirra sem magasýruseytishemla
HK1085205A1 (en) Benzimidazole quinolinones and uses thereof
DK3366283T3 (da) Direkte sammenpresningsformulering og fremgangsmåde
ITTO20030793A1 (it) Apparecchiatura e procedimento per la trivellazione
IS7701A (is) Arípíprazól samsett lyfjaform og aðferð
IS7801A (is) Púrín efnasambönd og notkun þeirra sem kannabinóíð viðtaka bindla
IS7520A (is) Pyrimidínonefnasambönd, samsetningar og aðferðir
IS2529B (is) Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
IS7792A (is) Hýdantóínafleiður og notkun þeirra sem TACE hemla
IS7700A (is) Ný spíróþétt kínasólínón og notkun þeirra sem fosfórdíesterasa hindrar
DK1483247T3 (da) Arylsubstituerede pyrimidiner og anvendelsen deraf
IS7749A (is) Pýrimídínafleiður og notkun þeirra sem CB2 beina
IS7470A (is) Kínólínafleiður og notkun þeirra sem 5-HT6 tengla
NO20054433D0 (no) Methods and devices for building construction
IS8392A (is) Heterósýklískir hindrar MEK og notkun þeirra
IS7434A (is) N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
NO20055568D0 (no) Substituerte 1,4-diazepiner og anvendelser derav
IS8220A (is) Bensímídasólafleiður, blöndur sem innihalda þær, framleiðsla þeirra og notkun
FI20020001A0 (fi) Palonsammutusmenetelmõ ja -laitteisto
DK1814977T3 (da) Arthrospira-baserede sammensætninger og anvendelser deraf
IS7783A (is) Flóð og fjöru-ker
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1562918T3 (da) Substituerede benzoxazinoner og anvendelser deraf
AU2003215756A8 (en) Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
DK1589938T3 (da) Mundplejesammensætninger og fremgangsmåder hertil